Ampio Pharmaceuticals Inc.
AMPE
AMPE was delisted on the 12th of April, 2024.
131 hedge funds and large institutions have $33.7M invested in Ampio Pharmaceuticals Inc. in 2021 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 33 increasing their positions, 35 reducing their positions, and 6 closing their positions.
493% more call options, than puts
Call options by funds: $646K | Put options by funds: $109K
183% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 6
8% more funds holding
Funds holding: 121 → 131 (+10)
6% less repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 35
54% less capital invested
Capital invested by funds: $72.6M → $33.7M (-$38.9M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CH
CVI Holdings
Wilmington,
Delaware
|
+$6.43M |
| 2 |
Renaissance Technologies
New York
|
+$2.99M |
| 3 |
BlackRock
New York
|
+$2.05M |
| 4 |
D.E. Shaw & Co
New York
|
+$928K |
| 5 |
Barclays
London,
United Kingdom
|
+$195K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$205K |
| 2 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$183K |
| 3 |
Simplex Trading
Chicago,
Illinois
|
-$183K |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$148K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$139K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
MA
126
MUFG Americas
New York
| $1K | – | – | – |
|
|
UB
127
UMB Bank
Kansas City,
Missouri
| $1K | +$1.12K | +3 | New |
|
|
MBFW
128
Morton Brown Family Wealth
Allentown,
Pennsylvania
| $1K | +$2.24K | +6 | New |
|
|
GEA
129
Glen Eagle Advisors
Kingston,
New Jersey
| $570 | – | – | – |
|
130
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $28 | -$75.7K | -203 | -56% |
|
|
HIS
131
Harvest Investment Services
Oakbrook Terrace,
Illinois
| – | -$86K | -174 | Closed |
|
|
MLICM
132
Metropolitan Life Insurance Company (MetLife)
New York
| – | -$53.9K | -108 | Closed |
|
|
MIM
133
MetLife Investment Management
Whippany,
New Jersey
| – | -$51.4K | -103 | Closed |
|
|
BFG
134
Baron Financial Group
Fair Lawn,
New Jersey
| – | -$39K | -78 | Closed |
|
135
Jane Street
New York
| – | -$30K | -61 | Closed |
|
|
CAGAS
136
Capital Advisory Group Advisory Services
Bloomington,
Minnesota
| – | -$2K | -3 | Closed |
|
AMPE Hedge Fund Activity: Q4 2021 in Review
131 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q4 2021, worth a combined $33.7M — down 54% from $72.6M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new AMPE positions and 6 closed out — a net gain of 11 holders — while 33 added to existing stakes and 35 trimmed.
The largest buyer was CVI Holdings, opening a new position worth an estimated $6.43M. The largest seller was Susquehanna International Group, cutting an estimated $205K.
- 131 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q4 2021, up from 121 in Q3 2021.
- Funds reported $33.7M of Ampio Pharmaceuticals Inc. stock for Q4 2021, down 54% quarter-over-quarter.
- 17 funds opened new Ampio Pharmaceuticals Inc. positions in Q4 2021 and 6 closed out, a net change of +11 holders.
- The largest Ampio Pharmaceuticals Inc. buyer in Q4 2021 was CVI Holdings, an estimated $6.43M added.
- The largest Ampio Pharmaceuticals Inc. seller in Q4 2021 was Susquehanna International Group, an estimated $205K sold.
Based on aggregated 13F filings for Q4 2021.